Managing Chemotherapy patients during the COVID-19 crisis – A Clinical Pharmacy Congress Webinar in Partnership with BOPA

A Clinical Pharmacy Congress Webinar in Partnership with BOPA

 

Speaker – Steve Williamson, Lead Cancer Pharmacist, NHS England and NHS Improvement and previous Chair of BOPA

 

Discussion of the interim chemotherapy treatment options funded during the crisis and the NHS England / NICE clinical guidelines.

Will provide a run-through of how the NHS in England managed the commissioning of new interim chemotherapy treatments to benefit patients during COVID-19 including

• Discussion of the rationale for why treatments were chosen
• Discussion of the clinical benefits tool that was developed to inform decision making
• Presentation of the latest uptake figures for interim treatments
• Discussion of how things will change in future

 

Register and see event page HERE

Latest News

By Suriya Marshall on 14th March 2026

Parliamentary Intervention Sparks National Campaign to Protect NHS Staff from Hazardous Medicinal Products (HMPs)

First UK Campaign to Protect Healthcare Workers from Exposure to Hazardous Medicinal Products (HMPs) launches in Westminster London, 10 March 2026: Today, the Safer Healthcare and Biosafety Network (SHBN) launches…

Read article
By Suriya Marshall on 14th March 2026

Clinical Pharmacy Congress. 8th-9th May 2026

Dear BOPA member, We are excited to announce that we have partnered with Clinical Pharmacy Congress 2026. Clinical Pharmacy Congress is the UK’s leading event for clinical pharmacy professionals working across…

Read article
By BOPA Executive Committee on 13th March 2026

First UK Campaign to Protect Healthcare Workers from Exposure to Hazardous Medicinal Products (HMPs) launches in Westminster

London, 10 March 2026: The Safer Healthcare and Biosafety Network (SHBN) launches a new campaign titled “Protecting Healthcare Workers: Safer Handling of Hazardous Medicinal Products” to raise awareness of the dangers…

Read article
By BOPA on 13th March 2026

Invitation to Participate: SWEET-PLUS Study

You are invited to take part in a research study called SWEET-PLUS (NIHR Research for Patient Benefit: 207952), run by Newcastle and Oxford Brookes Universities. SWEET-PLUS aims to understand experiences…

Read article